Scholar Rock Holding (SRRK) Profit After Tax Growth (3y) (2020 - 2026)
Scholar Rock Holding (SRRK) Profit After Tax Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PAT Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
860,679.92 Bn |
860,679.89 Bn |
- |
- |
| 2 |
Belite Bio |
55,284.00 Bn |
55,284.00 Bn |
- |
84.25% |
| 3 |
Quantum Biopharma |
16,206.94 Bn |
16,206.93 Bn |
- |
33.21% |
| 4 |
Legend Biotech |
3,318.00 Bn |
3,317.71 Bn |
242.10 Mn |
30.60% |
| 5 |
Akari Therapeutics |
1,543.84 Bn |
1,543.84 Bn |
- |
-154.28% |
| 6 |
Evaxion A |
1,449.11 Bn |
1,449.09 Bn |
- |
16.53% |
| 7 |
Psyence Biomedical |
216.99 Bn |
216.98 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
115.22 Bn |
107.97 Bn |
2.59 Bn |
13.80% |
| 9 |
Abivax |
90.58 Bn |
90.58 Bn |
- |
- |
| 10 |
Scholar Rock Holding |
5.80 Bn |
5.32 Bn |
- |
-38.89% |
| Date | Value |
|---|
| Mar 31, 2026 |
-38.89% |
| Dec 31, 2025 |
-32.33% |
| Sep 30, 2025 |
-33.16% |
| Jun 30, 2025 |
-35.73% |
| Mar 31, 2025 |
-111.04% |
| Dec 31, 2024 |
-22.77% |
| Sep 30, 2024 |
-19.79% |
| Jun 30, 2024 |
-23.97% |
| Mar 31, 2024 |
-27.13% |
| Dec 31, 2023 |
-20.18% |
| Sep 30, 2023 |
-21.60% |
| Jun 30, 2023 |
-25.29% |
| Mar 31, 2023 |
-32.13% |
| Dec 31, 2022 |
-50.25% |
| Sep 30, 2022 |
-38.93% |
| Jun 30, 2022 |
-52.02% |
| Mar 31, 2022 |
9.58% |
| Dec 31, 2021 |
-33.88% |
| Sep 30, 2021 |
-51.61% |
| Jun 30, 2021 |
-27.81% |
